Close Menu

NEW YORK – Fulgent Genetics' stock rose as much as 12 percent on Wednesday following an announcement that the firm has partnered with Florida's Miami-Dade County on COVID-19 testing.

Under the deal, the Temple City, California-based genetic testing firm will provide RT-PCR-based COVID-19 tests as well as its community testing platform for managing drive-through testing sites. Financial and other details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.